{
  "company": {
    "name": "Axelyf",
    "website": "https://axelyf.com/",
    "record": "https://startuphistory.org/c/axelyf.com"
  },
  "status": null,
  "history_since": "2023-03-23T03:26:09.000Z",
  "baseline": {
    "snapshot_id": "b7ea7ec58a6b97ab0a43f3d02029c7071d618c6c76a22cf22cae951e69dd86a3",
    "observed_at": "2023-03-23T03:26:09.000Z",
    "headline": "Intelligent Drug Design",
    "description": "“The next big fibrosis drug does not have to be discovered... it is here to be engineered for delivery”",
    "evidence": "https://web.archive.org/web/20230323032609/https://axelyf.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-05T11:45:26.718Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2024-06-01T21:39:55.000Z",
      "variants": [
        {
          "headline": "Intelligent Drug Design",
          "subhead": "“The next big fibrosis drug does not have to be discovered... it is here to be engineered for delivery”",
          "observed_at": "2023-03-23T03:26:09.000Z",
          "evidence": "https://web.archive.org/web/20230323032609/https://axelyf.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Intelligent Drug Design",
          "subhead": "“Innovative therapeutics, engineered and delivered”",
          "observed_at": "2024-06-01T21:39:55.000Z",
          "evidence": "https://web.archive.org/web/20240601213955/https://axelyf.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Intelligent Drug Design",
      "subhead": "“Innovative therapeutics, engineered and delivered”",
      "from": "2023-03-23T03:26:09.000Z",
      "to": "2024-06-01T21:39:55.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20240601213955/https://axelyf.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2023-03-23T03:26:09.000Z",
          "to": "2024-06-01T21:39:55.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-05T11:45:26.718Z",
      "variants": [
        {
          "headline": "Axelyf ehf",
          "subhead": null,
          "observed_at": "2024-08-19T05:32:22.000Z",
          "evidence": "https://web.archive.org/web/20240819053222/https://www.axelyf.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Axelyf ehf",
          "subhead": null,
          "observed_at": "2025-01-14T10:39:37.000Z",
          "evidence": "https://web.archive.org/web/20250114103937/https://www.axelyf.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Axelyf ehf",
          "subhead": "Advancing RNA medicines through safer and more effective lipid nanoparticle delivery.",
          "observed_at": "2025-08-29T11:42:56.000Z",
          "evidence": "https://web.archive.org/web/20250829114256/https://www.axelyf.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Axelyf ehf",
          "subhead": "Advancing RNA medicines through safer and more effective lipid nanoparticle delivery.",
          "observed_at": "2025-08-29T12:43:22.000Z",
          "evidence": "https://web.archive.org/web/20250829124322/https://www.axelyf.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Axelyf, Inc.",
          "subhead": "Building Next-Generation RNA-LNP Therapeutics: experienced drug developers with distinctive technologies - for partners, programs and patients",
          "observed_at": "2026-04-15T11:04:20.000Z",
          "evidence": "https://web.archive.org/web/20260415110420/https://www.axelyf.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Axelyf, Inc.",
          "subhead": "Building Next-Generation RNA-LNP Therapeutics: experienced drug developers with distinctive technologies - for partners, programs and patients",
          "observed_at": "2026-10-13T09:17:25.000Z",
          "evidence": "https://web.archive.org/web/20261013091725/https://www.axelyf.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Axelyf, Inc.",
          "subhead": "Building Next-Generation RNA-LNP Therapeutics: experienced drug developers with distinctive technologies - for partners, programs and patients",
          "observed_at": "2026-11-05T11:45:26.718Z",
          "evidence": "https://www.axelyf.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Axelyf, Inc.",
      "subhead": "Building Next-Generation RNA-LNP Therapeutics: experienced drug developers with distinctive technologies - for partners, programs and patients",
      "from": "2024-08-19T05:32:22.000Z",
      "to": "2026-11-05T11:45:26.718Z",
      "captures": 7,
      "evidence": "https://www.axelyf.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2024-08-19T05:32:22.000Z",
          "to": "2026-11-05T11:45:26.718Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Axelyf” company record, https://startuphistory.org/c/axelyf.com"
}